The Center for World Health and Medicine, the University of Missouri-St. Louis Medicinal Chemistry Group, and the Institute for One World Health have joined forces “to develop safe and effective anti-diarrhea drugs … aimed at preventing the massive water and electrolyte secretion that occurs in severe diarrhea,” which causes dehydration and electrolyte imbalance, the primary causes of death from diarrheal diseases, the St. Louis Beacon reports.

The group hopes “[i]f the anti-diarrheal pill works to get children through the acute phase of their illness, the door might be open to bring in other strategies like personal water purification systems and education in personal hygiene, in collaboration with SLU’s School of Public Health or other non-profit organizations,” the Beacon writes (Seltzer, 6/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.